CDL Kasauli clears almost 6.5 crore doses of Corbevax: Sources
Deccan ChronicleNew Delhi: The Central Drugs Laboratory, Kasauli, has cleared almost 6.5 crore doses of Biological E's COVID-19 vaccine Corbevax based on safety, quality and efficacy parameters, sources said on Tuesday. The country's central drug authority has already approved COVID-19 vaccine, Corbevax, for restricted use in emergency situations among adults on December 28, 2019. Earlier sources on condition of anonymity told ANI that the Central Government has placed an order for as many as five crores Biological E's vaccine Corbevax. The Hyderabad-based pharmaceutical company Biological E on Monday received Emergency Use Authorization approval from Drugs Controller General of India for its COVID-19 vaccine Corbevax to be administered between the age group of 12 to 18 years.